New number of shares and voting rights for Innate Pharma

On August 4, 2025, Innate Pharma announced updated figures for the number of shares and voting rights as of August 1, 2025. The company now has 92,184,823 ordinary shares, accompanied by 6,424 2016 Preferred Shares and 7,581 2017 Preferred Shares. The number of theoretical voting rights is 92,962,943, while the number of exercisable voting rights is 92,944,368.

This update complies with the regulations of the French Commercial Code and the Autorité des marchés financiers. The details provided include the nuances between "gross" and "net" voting rights, taking into account the AMF's recommendations for public transparency. Innate Pharma is listed on Euronext Paris and Nasdaq.